TANCE SONNIER: Open Payments
NPI 1699496612 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,216 in 112 payments from 22 companies in 2025. Trend: 2023 $2,475 · 2024 $2,431 · 2025 $2,216
Food & beverage: $2,214Education: $2
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $479 |
| Vanda Pharmaceuticals Inc. | 12 | $422 |
| PFIZER INC. | 15 | $244 |
| BETA BIONICS, INC. | 5 | $165 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $153 |
| GlaxoSmithKline, LLC. | 6 | $119 |
| Xeris Pharmaceuticals, Inc. | 4 | $98 |
| Corcept Therapeutics | 4 | $95 |
| Novo Nordisk Inc | 4 | $76 |
| Lilly USA, LLC | 4 | $63 |
Products named: FANAPT, VRAYLAR, iLet Bionic Pancreas, Kerendia, QULIPTA, UBRELVY, TRELEGY ELLIPTA, ELIQUIS.
Industry payments across LA — which companies pay providers there.
